Although a few studies have shown that an anti-CD47 antibody monotherapy was able to inhibit tumor growth in some syngeneic mouse models [21], most studies in syngeneic mouse models and in clinical trials reported that anti-CD47 antibody alone did not exert significant antitumor effects [16, 22, 48, 49]. Here, CD47 is linked to neoplasm.